Copyright
©The Author(s) 2016.
World J Nephrol. Jul 6, 2016; 5(4): 372-377
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.372
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.372
Table 2 The medications used by the patients
| Drug | n (%) | Drug | n (%) |
| Calcium-containing phosphorus binders | 27 (71) | Alpha blockers | 6 (16) |
| Diuretics | 25 (66) | Acetylsalicylic acid | 6 (16) |
| Active vitamin D | 21 (55) | RAS blockers | 5 (13) |
| Erythropoiesis stimulating agents | 20 (53) | Cinecalcet | 5 (13) |
| Calcium channel blockers | 18 (47) | Allopurinol | 3 (7) |
| Beta blockers | 13 (34) | Fibrates | 1 (2.6) |
| Statins | 14 (37) | Sevalemer | 1 (2.6) |
| Essential amino acid | 10 (26) |
- Citation: Gursu M, Uzun S, Topcuoğlu D, Koc LK, Yucel L, Sumnu A, Cebeci E, Ozkan O, Behlul A, Koc L, Ozturk S, Kazancioglu R. Skin disorders in peritoneal dialysis patients: An underdiagnosed subject. World J Nephrol 2016; 5(4): 372-377
- URL: https://www.wjgnet.com/2220-6124/full/v5/i4/372.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i4.372